AGLSL

Artemis Global Life Sciences Limited has informed the Exchange regarding Board meeting held on August 14, 2019.

Artemis Global Life Sciences Limited has informed the Exchange regarding Outcome of Board Meeting held on May 08, 2019.

Artemis Global Life Sciences Limited has informed the Exchange regarding Board meeting held on February 04, 2019.Sub: Outcome of the Board Meeting held on 04th February, 2019Dear Sir/ Madam,In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, we wish to inform you that Board of Directors of the Company in their meeting held on 04.02.2019 have inter alia, considered and approved the un-audited financial results (standalone & consolidated) for the quarter ended 31st December, 2018 as recommended by Audit Committee.Pursuant to Regulation 33 of

Artemis Global Life Sciences Limited has informed the Exchange regarding Board meeting held on November 12, 2018.Sub: Outcome of the Board Meeting held on 12th November, 2018Dear Sir/ Madam,In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, we wish to inform you that Board of Directors of the Company in their meeting held on 12th November, 2018 have inter alia approved the following:1. On recommendation of the Audit Committee, the Board of Directors have approved un-audited financial results (standalone & consolidated) of the Company for

Artemis Global Life Sciences Limited has informed the Exchange regarding Outcome of Board Meeting held on August 03, 2018.

Artemis Global Life Sciences Limited has informed the Exchange regarding Outcome of Board Meeting held on August 03, 2018.Dear Sir/ Madam,In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 we wish to inform you that Board of Directors of the Company in their meeting held on 03.08.2018 have inter alia, considered and approved the un-audited financial results (standalone & consolidated) for the quarter ended 30th June, 2018 as recommended by Audit Committee.Pursuant to Regulation 33 of SEBI (Listing Obligations Disclosure Requirements) Regula

Artemis Global Life Sciences Limited has informed the Exchange regarding Outcome of Board Meeting held on May 09, 2018.

Artemis Global Life Sciences Limited has informed the Exchange regarding Outcome of Board Meeting held on May 09, 2018.Dear Sir/ Madam,We wish to inform you that Board of Directors of the Company in their meeting held on 09.05.2018 have inter alia approved the following:1. On recommendation of the Audit Committee, the Board of Directors has approved audited financial results (standalone & consolidated) of the Company under Indian Accounting Standards (IND AS) for the quarter/ year ending March 31, 2018.Pursuant to Regulation 33 of SEBI (Listing Obligations Disclosure Requirements) Regulations,

Artemis Global Life Sciences Limited has informed the Exchange regarding Outcome of Board Meeting held on February 05, 2018.

Artemis Global Life Sciences Limited has informed the Exchange regarding Outcome of Board Meeting held on October 31, 2017.In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 we wish to inform you that Board of Directors of the Company in their meeting held on 31.10.2017 have inter alia, considered and approved the unaudited financial results for the quarter and half year ended 30th September, 2017 as recommended by Audit Committee.Further Pursuant to Regulation 33 of SEBI (Listing Obligations Disclosure Requirements) Regulations, 2015, a co

Artemis Global Life Sciences Limited has informed the Exchange regarding Outcome of Board Meeting held on August 04, 2017. Appointment of Ms. Devlina Chakravarty as Managing Director and Mr. US Anand, Independent Director.